DCGI permits Bharat Biotech to conduct trials for intranasal booster dose
New Delhi: In a major development on Friday, the Drugs Controller General of India (DCGI) allowed Hyderabad-based vaccine manufacturer Bharat Biotech to conduct clinical trials































